Czasopismo Przegląd Gastroenterologiczny 2026

Konrad Lewandowski, Katarzyna Karłowicz, Joanna Sarbinowska, Maciej Gonciarz, Dagmara Mahadea, Liliana Łykowska-Szuber, Piotr Eder, Anna Chaber-Ciopińska, Edyta Zagórowicz, Grażyna Rydzewska

Gastroenterology Rev 2026; 21 (1): 38–44

DOI: https://doi.org/10.5114/pg.2026.159896

Abstract View text (PDF)

Original paper

Women in gastroenterology: what is the current situation? Results of a Polish National Survey

Aleksandra Sobolewska-Włodarczyk, Aleksandra Jagura-Sukiennik, Julia Wawerska, Anita Gąsiorowska

Gastroenterology Rev 2026; 21 (1): 45–48

DOI: https://doi.org/10.5114/pg.2026.160373

Abstract View text (PDF)

Original paper

Irritable bowel syndrome clinical trials: getting the IBS Severity Scoring System responder rate right

Henning Sommermeyer, Krzysztof Chmielowiec, Paulina Wojtyła-Buciora, Malgorzata Bernatek, Pawel Olszewski, Zygmunt Kopczynski, Jacek Piatek

Gastroenterology Rev 2026; 21 (1): 49–54

DOI: https://doi.org/10.5114/pg.2025.156735

Abstract View text (PDF)

Original paper

Global trend of organoid implementation for hepatocellular carcinoma research (2005–2024): bibliometric analysis

Changsheng Ji, Hui Zhao, Ying Shui, Wangpeng Zhao, Lishuai Qu

Gastroenterology Rev 2026; 21 (1): 55–72

DOI: https://doi.org/10.5114/pg.2026.160529

Abstract View text (PDF)

Original paper

The potential role of serum miR-182-5p and miR-127-5p in diagnosis of metabolic dysfunction-associated steatotic liver disease and its relationship with insulin resistance

Tarek I. Ahmed, Esraa A. Mahmoud, Naglaa R. Ismael, Omayma O. Abdelaleem, Nada F. Hemeda, Heba A. El-Dash, Abeer A. Khalifa, Ragab A. Ali

Gastroenterology Rev 2026; 21 (1): 73–81

DOI: https://doi.org/10.5114/pg.2026.160545

Abstract View text (PDF)

Original paper

Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease

Doaa Abdou Header, Abeer Mahmoud Ali Ibrahim, Asmaa Mahdy Ramadan, Fatma Ibrahim Dwedar, Khaled Abdel Aty

Gastroenterology Rev 2026; 21 (1): 82–87

DOI: https://doi.org/10.5114/pg.2026.160534

Abstract View text (PDF)

Original paper

The effect of gastrojejunostomy on carbohydrate metabolism in patients with pancreatic cancer

Oliwia Grząsiak-Kraj, Alicja Majos, Adam Durczyński, Piotr Hogendorf, Nela Hejduk, Janusz Strzelczyk

Gastroenterology Rev 2026; 21 (1): 88–96

DOI: https://doi.org/10.5114/pg.2026.160484

Abstract View text (PDF)

Original paper

Dynamic platelet count value as a clinical indicator of postoperative pancreatic fistula after pancreatic resections

Maria Papadoliopoulou, Francesk Mulita, Ioannis Margaris, Mirto Moutafi, Dimitrios Vouros, Theodoros Sidiropoulos, Panagiotis Kokoropoulos, Konstantinos Toutouzas, Nikolaos V. Michalopoulos, Nikolaos Arkadopoulos

Gastroenterology Rev 2026; 21 (1): 97–102

DOI: https://doi.org/10.5114/pg.2026.160542

Abstract View text (PDF)

Letter to the Editor

Hypoglycaemia in a patient with huge hepatocellular carcinoma responsive to chemoembolisation and tumour resection

Helen Bolanaki, Francesk Mulita, Athanasia Mitsala, Anastasios Zorbalas, Ioannis Tzimagiorgis, Anastasios J. Karayiannakis

Gastroenterology Rev 2026; 21 (1): 103–107

DOI: https://doi.org/10.5114/pg.2026.160318

View text (PDF)

Letter to the Editor

Vedolizumab as a first-choice biological treatment of Crohn’s disease in a patient with paraganglioma of the nervous system

Patrycja Szałwińska, Ewa Malecka-Wojciesko

Gastroenterology Rev 2026; 21 (1): 108–110

DOI: https://doi.org/10.5114/pg.2026.160317

View text (PDF)

Letter to the Editor

Unusual origin of a pancreatic head mass

Idris Kurt, Yalçın Taymez, Görkem Karadağ, Bahar Kandemir, Türkay Demirbozan, Hasan C. Ümit, Hüseyin A. Tezel, Ali R. Soylu

Gastroenterology Rev 2026; 21 (1): 111–114

DOI: https://doi.org/10.5114/pg.2026.160315

View text (PDF)

Letter to the Editor

Chronic pancreatitis associated with genetic mutation and drug-resistant epilepsy

Magdalena W. Koczyńska, Ewa Małecka-Wojciesko, Ludomir Stefańczyk

Gastroenterology Rev 2026; 21 (1): 115–118

DOI: https://doi.org/10.5114/pg.2026.160312

View text (PDF)

Liver function disorders in pregnancy: physiology or pathology?

Personalised therapy in pancreatic carcinoma – a forthcoming opportunity?

Diverticular disease increases the risk of acute myocardial infarction

Gastroenterological disorders in inborn errors of immunity. Part 2 A. Overview of selected diseases

A comprehensive review of usefulness of sodium butyrate for the management of inflammatory bowel disease: from molecular mechanisms to clinical application

RESCUE-CD – Real-world effectiveness of risankizumab in moderate-to-severe Crohn’s disease: a case series involving the most refractory and challenging patients

Women in gastroenterology: what is the current situation? Results of a Polish National Survey

Irritable bowel syndrome clinical trials: getting the IBS Severity Scoring System responder rate right

Global trend of organoid implementation for hepatocellular carcinoma research (2005–2024): bibliometric analysis

The potential role of serum miR-182-5p and miR-127-5p in diagnosis of metabolic dysfunction-associated steatotic liver disease and its relationship with insulin resistance

Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn’s disease

The effect of gastrojejunostomy on carbohydrate metabolism in patients with pancreatic cancer

Dynamic platelet count value as a clinical indicator of postoperative pancreatic fistula after pancreatic resections

Hypoglycaemia in a patient with huge hepatocellular carcinoma responsive to chemoembolisation and tumour resection

Vedolizumab as a first-choice biological treatment of Crohn’s disease in a patient with paraganglioma of the nervous system

Unusual origin of a pancreatic head mass

Chronic pancreatitis associated with genetic mutation and drug-resistant epilepsy

Coverage in

Indexed in

Integrated with

Editorial Policies